These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37103652)

  • 1. Metabolic profiling of patients with different idiopathic inflammatory myopathy subtypes reveals potential biomarkers in plasma.
    Zhao Q; Hu Q; Meng S; Zhang Q; Wang T; Liu C; Liu D; Jiang Z; Hong X
    Clin Exp Med; 2023 Nov; 23(7):3417-3429. PubMed ID: 37103652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated analysis of plasma and urine reveals unique metabolomic profiles in idiopathic inflammatory myopathies subtypes.
    Liu D; Zhao L; Jiang Y; Li L; Guo M; Mu Y; Zhu H
    J Cachexia Sarcopenia Muscle; 2022 Oct; 13(5):2456-2472. PubMed ID: 35860906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymyositis is a rare and favourable outcome subtype of idiopathic inflammatory myopathy in Chinese patients.
    Sun C; Tian X; Yang H; Yang H; Li S; Jiang W; Peng Q; Wang G; Lu X
    Clin Exp Rheumatol; 2024 Feb; 42(2):302-308. PubMed ID: 38488095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma proteomic profiling reveals KRT19 could be a potential biomarker in patients with anti-MDA5+ dermatomyositis.
    Zhang P; Li M; Zhang Y; Lian C; Sun J; He Y; Hu W; Wang L; Li T; Liu S; Zhang Y
    Clin Rheumatol; 2023 Aug; 42(8):2145-2154. PubMed ID: 37160775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different Multivariable Risk Factors for Rapid Progressive Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis and Anti-Synthetase Syndrome.
    Zuo Y; Ye L; Chen F; Shen Y; Lu X; Wang G; Shu X
    Front Immunol; 2022; 13():845988. PubMed ID: 35320936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum metabolomic analysis reveals disorder of steroid hormone biosynthesis in patients with idiopathic inflammatory myopathy.
    Huo T; Yuan X; Han J; Shi J; Xiong Y; Tian F; Xu Z; Cai M; Xu Y; Chen H; Zeng X; He W; Wang Q; Zhang J
    Front Immunol; 2023; 14():1188257. PubMed ID: 37377960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of Complement, Microangiopathy and Inflammation in Idiopathic Inflammatory Myopathies.
    Honda M; Shimizu F; Sato R; Nakamori M
    J Neuromuscul Dis; 2024; 11(1):5-16. PubMed ID: 38143369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in epigenetic markers of dermatomyositis/polymyositis].
    Yang YY; Zuo XX; Zhu HL; Liu SJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Apr; 51(2):374-377. PubMed ID: 30996386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.
    Loarce-Martos J; Lilleker JB; Parker M; McHugh N; Chinoy H
    Rheumatology (Oxford); 2021 Jul; 60(7):3398-3403. PubMed ID: 33367878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum of idiopathic inflammatory myopathies in South Africa.
    Chinniah KJ; Mody GM
    Clin Rheumatol; 2021 Apr; 40(4):1437-1446. PubMed ID: 32212001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using multi-omics methods to understand dermatomyositis/polymyositis.
    Gao S; Luo H; Zhang H; Zuo X; Wang L; Zhu H
    Autoimmun Rev; 2017 Oct; 16(10):1044-1048. PubMed ID: 28778709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic inflammatory myopathies: a review.
    Ashton C; Paramalingam S; Stevenson B; Brusch A; Needham M
    Intern Med J; 2021 Jun; 51(6):845-852. PubMed ID: 34155760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and Prevalence of Idiopathic Inflammatory Myopathies in Korea: a Nationwide Population-based Study.
    Cho SK; Kim H; Myung J; Nam E; Jung SY; Jang EJ; Yoo DH; Sung YK
    J Korean Med Sci; 2019 Mar; 34(8):e55. PubMed ID: 30833879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Classification of idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific antibodies].
    Zheng S; Chen S; Wu L; Zhao D; Chen F; Zhu J; Li J
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jul; 40(7):1029-1035. PubMed ID: 32895158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort.
    Dobloug GC; Garen T; Brunborg C; Gran JT; Molberg Ø
    Semin Arthritis Rheum; 2015 Dec; 45(3):301-8. PubMed ID: 26190563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies.
    Yoo J; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Korean J Intern Med; 2021 Mar; 36(2):441-446. PubMed ID: 31875667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major histocompatibility complex class I and II expression in idiopathic inflammatory myopathy.
    Das L; Blumbergs PC; Manavis J; Limaye VS
    Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):539-42. PubMed ID: 23343957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymyositis and dermatomyositis biomarkers.
    Xu S; Hu X; Wang J; Xu Q; Han Z; Zhou H; Gao M
    Clin Chim Acta; 2023 Jul; 547():117443. PubMed ID: 37329941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous Immunoglobulin in Idiopathic Inflammatory Myopathies: a Practical Guide for Clinical Use.
    Gandiga PC; Ghetie D; Anderson E; Aggrawal R
    Curr Rheumatol Rep; 2023 Aug; 25(8):152-168. PubMed ID: 37261663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic inflammatory myopathy: clinicopathological observations in the Indian population.
    Prasad ML; Sarkar C; Roy S; Bagchi U; Singh RR; Singh YN; Sharma S; Malaviya AN
    Br J Rheumatol; 1992 Dec; 31(12):835-9. PubMed ID: 1458290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.